March 6, 1990

A method for increasing cardiotonic contractility in humans or other animals using a class of benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds and pharmaceutical compositions including the same.

18

March 6, 1990

07/255,664

October 11, 1988

514/252.02   514/218 514/221 514/249 514/252.06 514/266.23 514/387 540/493 540/495 540/500 540/543 540/567 540/570 544/119 544/230 544/231 544/235 544/237 544/238 544/249 544/284 544/354

C07D   403/04   (20060101)   C07D   403/00   (20060101)  

This is a division of co-pending application Ser. No. 063,481, filed on Jun. 17, 1987, now U.S. Pat. No. 4,785,101, which is a division of application Ser. No. 800,986, filed on Nov. 22, 1985, now U.S. Pat. No. 4,725,686.

514/254   514/213   514/249   514/259   514/387  

	6531458 - Stable compositions comprising levosimendan and alginic acid - Owned by Orion Corporation (Espoo,FI) The present invention relates to pharmaceutical compositions of levosimendan comprising alginic acid for improving the stability of levosimendan in the compositions. Levosimendan is useful in the treatment of congestive heart failure.
	7429598 - Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors - Owned by Warner-Lambert Company (Morris Plains, NJ) The invention relates to compounds of formula (I) ##STR00001## wherein R.sup.1, R.sup.2 and m are as defined in the description, their use as medicament, pharmaceutical compositions containing them and a process for their preparation.